A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : SD / serologically defined

[Related PubMed/MEDLINE]
Total Number of Papers: 29
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   SD  (>> Co-occurring Abbreviation)
Long Form:   serologically defined
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
1981 Early detection and specificity analysis of human cytolytic T lymphocyte (CTL) colonies generated in soft agarose culture: a potential assay for definition of CTL defined (CD) determinants. CD, CML, CTL, MLC
1980 Genetics of kidney allograft survival in dogs. III. Relevance of histocompatibility matching in immunosuppressed recipients. DRPs, LD, MHC
1980 In vitro generation of human mixed lymphocyte culture suppressor cells. I. Cellular characterization and specificity. LD, MLC, PBLs
1980 Serologically detectable HLA-A, B, and C loci antigens in farmer's lung disease. ---
1980 Serum and cell-mediated cytotoxicity after primary and secondary orthotopic tooth transplants among RhLA-paired rhesus monkeys. CDC, LMC, MLCs
1979 Definition of two LD antigens in rhesus monkeys. LD, MLC
1979 Genetics of kidney allograft survival in dogs. I. Relevance of subregions of the major histocompatibility complex in recipients without immunosuppressive therapy. MHC, MLR
1978 Recombination between genes coding for immune response and the serologically determined antigens in the chickenB system. ---
1978 Serologically defined (SD) locus in cattle. ---
10  1978 The major histocompatibility complex of rhesus monkeys. VIII. Isolation and partial characterization of SD antigens. ---
11  1977 In vitro studies of transplantation antigens present on bone cells in the rat. ---
12  1977 Lack of association between Hashimoto's thyroiditis and SD-locus HLA antigens. ---
13  1977 The importance of serologically detectable histocompatibility antigens in the induction and effector step of cell-mediated lysis. CMC, TNP
14  1977 The major histocompatibility complex of rhesus monkeys, RhL--A. VII. Identification of five new serologically defined antigens. MHC
15  1976 Genetic studies in inbred rats. VII. Tentative model for the major histocompatibility complex. Ir, LD, MHC
16  1976 HLA factors and immune function. Ir, MHS
17  1976 Marrow grafts between canine litter-mates homozygous or heterozygous for lymphocyte-defined histocompatibility antigens. GVHD, LD, MHC
18  1976 Recognitive specificity of human cytotoxic T lymphocytes. II. The non-recognition of antigens controlled outside the major histocompatibility complex. CTLs, MHC
19  1976 Secondary cytotoxic allograft responses in vitro. III. The immunogenicity of allogeneic membrane fragments. CTL
20  1976 The major histocompatibility complex of rhesus monkeys. VI. Serology and genetics of Ia-like antigens. ---
21  1976 The serologically-defined (SD) private and public specificities and their genetic control of T cell mediated cytotoxicity: a discussion [proceedings]. ---
22  1975 Cell-mediated immunity to a serologically defined (SD) HL-A antigen panel in kidney-transplanted patients. LMAT
23  1975 Genetic and cellular control of in vitro models of allograft reactivity. MHC
24  1975 Recognitive specificity of human cytotoxic T lymphocytes. I. Antigen-specific inhibition of human cell-mediated lympholysis. CML, CTLs, MHC
25  1974 Genetic aspects of canine mixed leukocyte cultures. LD
26  1974 Role of H-2 lymphocyte-defined and serologically-defined components in the generation of cytotoxic lymphocytes. LD
27  1973 Atypical patterns of inheritance of the serologically detectable (SD) products of the HL-A complex in human developmental anomalies. ---
28  1973 Phenotypic expression of the main histocompatibility complex (DL-A) in randomly selected mongrel dogs. I. Serologically detectable (SD) DL-A antigens and mixed leukocyte (MLC) reactivity. MLC
29  1973 Phenotypic expression of the main histocompatibility complex (DL-A) in randomly selected mongrel dogs. II. Serologically detectable (SD) compatibility, MLC reactivity, and skin allograft survival. ---